Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
A Lehmann - Expert opinion on biological therapy, 2008 - Taylor & Francis
Background: Plasma kallikrein plays a major role in the contact (kallikrein–kinin) cascade
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery.
A Lehmann - Expert Opinion on Biological Therapy, 2008 - europepmc.org
Background Plasma kallikrein plays a major role in the contact (kallikrein-kinin) cascade
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …
[引用][C] Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
A Lehmann - Expert Opinion on Biological Therapy, 2008 - cir.nii.ac.jp
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema
and the prevention of blood loss in on-pump cardiothoracic surgery | CiNii Research CiNii …
and the prevention of blood loss in on-pump cardiothoracic surgery | CiNii Research CiNii …
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
A Lehmann - Expert opinion on biological therapy, 2008 - pubmed.ncbi.nlm.nih.gov
Background Plasma kallikrein plays a major role in the contact (kallikrein-kinin) cascade
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …
producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability …